WILSON-COOK MEDICAL INC PEG 24 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY SET - PULL; KNT, TUBE, GASTROINTESTINAL (AND ACCESSORIES)
|
Back to Search Results |
|
Catalog Number PEG-24-PULL-S |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abdominal Pain (1685); Scar Tissue (2060); Peritonitis (2252); Post Traumatic Wound Infection (2447); Gastrointestinal Hemorrhage (4476); Skin Infection (4544)
|
Event Type
Injury
|
Manufacturer Narrative
|
Investigation evaluation: a product evaluation was not performed in response to this report because the product said to be involved was not provided to cook for evaluation.The report could not be confirmed.A review of the device history record could not be conducted because the lot number was not provided.Investigation conclusion: we could not conduct a complete investigation because the product said to be involved was not returned for evaluation.A definitive cause for the reported observation could not be determined.The complications reported are known clinical complications.There is no evidence to suggest the report is due to a device failure.The ifu states the following potential complications: ¿potential complications associated with placement and use of a peg tube include, but are not limited to: bronchopulmonary aspiration and pneumonia, respiratory distress or airway obstruction, peritonitis or septic shock, colocutaneous, gastrocolocutaneous or small bowl fistula, gastric dilation, sigmoid intra-abdominal herniation and volvulus, persistent fistula following peg removal, esophageal injury, necrotizing fasciitis, candida cellulitis, improper placement of inability to place peg tube, tube dislodgement or migration, hemorrhage, and tumor metastasis." prior to distribution, all peg 24 percutaneous endoscopic gastrostomy set - pull are subjected to a visual and functional inspection to ensure device integrity.Corrective action: corrective action is not warranted at this time based on the quality engineering risk assessment.Quality assurance will continue to monitor for complaint trends and reassess the risk assessment results as post market feedback continues to become available.
|
|
Event Description
|
Cook endoscopy was notified of this event via a clinical literature article.This article was published in 2017.Please see below for relevant excerpts of this article.This study was based on a retrospective analysis of a prospectively collected database of all patients with hnc (head and neck cancer) who underwent peg at the cancer institute of sao paulo from december 2008 to october 2013.The indication for peg placement was made by the treating oncologist or head and neck surgeon.The following complications occurred " the subject of this report is the published: buried bumper syndrome (6 pts), peritonitis (1 pt), upper gi bleeding (1 pt), minor bleeding (1 pt), wound infection (15 pts), peristomal leakage (5 pts), abdominal pain (7 pts), granulation tissue (7 pts), dermatitis (3 pts).As published in the article.These adverse events were previously reported in 1037905-2022-00231 and are now being captured separately in this report.
|
|
Event Description
|
Cook endoscopy was notified of this event via a clinical literature article.This article was published in 2017.Please see below for relevant excerpts of this article.This study was based on a retrospective analysis of a prospectively collected database of all patients with hnc (head and neck cancer) who underwent peg at the (b)(6)institute from december 2008 to october 2013.The indication for peg placement was made by the treating oncologist or head and neck surgeon.The following complications occurred." the subject of this report is the published: buried bumper syndrome (6 pts), peritonitis (1 pt) , upper gi bleeding (1 pt), minor bleeding (1 pt), wound infection (15 pts), peristomal leakage (5 pts), granulation tissue (7 pts).Dermatitis (3 pts) as published in the article.These adverse events were previously reported in 1037905-2022-00231 and are now being captured separately in this report.
|
|
Manufacturer Narrative
|
This mdr is being submitted as a correction to remove the patients with abdominal pain (qty 7) from this report.Based on further quality and medical evaluation this incident no longer meets the reporting criteria of an fda mdr report.A separate record has been created in our complaint handling system to capture the event associated with the patients who experienced abdominal pain.
|
|
Search Alerts/Recalls
|
|
|